People: Cardiac Science Corporation (CSCX.O)

CSCX.O on Consolidated Issue listed on NASDAQ Global Market

2.58USD
10:09am EST
Price Change (% chg)

$-0.03 (-1.15%)
Prev Close
$2.61
Open
$2.59
Day's High
$2.60
Day's Low
$2.58
Volume
2,193
Avg. Vol
132,038
52-wk High
$5.69
52-wk Low
$2.00

view people for:

Summary

Name Age Since Current Position
Naumann-Etienne, Ruediger 63 2006 Chairman of the Board
Marver, David 41 2009 President, Chief Executive Officer, Director
Matysik, Michael 50 2005 Chief Financial Officer, Senior Vice President, Secretary
Odell, Robert 49 2009 Senior Vice President - Strategy, Design & Operations
Kingma, Peter 52 2009 Senior Vice President
Alberstone, Todd 50 2010 Vice President, General Counsel
Titus, Ralph 39 2007 Vice President - Marketing
Thompson, Barbara 52 2007 Vice President - Human Resources
Lemvigh, Kurt 49 2005 Vice President, International
Berg, W. Robert 65 2005 Director
Mickelson, Timothy 60 2006 Director
Davis, Christopher 57 2008 Director
Andrews, Ronald 50 2009 Director
» Insider Trading

Biographies

Name Description
Naumann-Etienne, Ruediger Ruediger Naumann-Etienne, Ph.D has served as one of the Directors of Cardiac Science Corporation and as Vice-Chairman from September 2005 to November 2006 and as Chairman since that date. Dr. Naumann-Etienne previously served as a director and Chairman of the Board of Directors of Quinton Cardiology Systems, Inc., one of the predecessor companies (“Quinton”) from April 2000 to August 2005, and as Chief Executive Officer of Quinton from November 2000 until September 2003. Dr. Naumann-Etienne is the owner and has been the Managing Director of Intertec Group, an investment company acting as a principal in managing high technology growth situations, since 1989. Dr. Naumann is also a director of Bio-Rad Laboratories, Inc., Encision, Inc. and Varian Medical Systems, Inc. Dr. Naumann-Etienne holds a Ph.D. in International Finance from the University of Michigan, an M.A. in Industrial Management from Georgia Institute of Technology and a B.A. in Economics from the Technical University of Berlin, Germany.
Marver, David Mr. David L. Marver has been appointed as President, Chief Executive Officer, Director of Cardiac Science Corporation since March 31, 2009. Mr. Marver previously served as Chief Operating Officer beginning in October 2008. Mr. Marver previously served as a medical device partner at Omega Fund Management, Inc. (a specialized investment fund with a focus in healthcare companies). From February 2002 to May 2008, Mr. Marver served in executive positions at Medtronic, Inc. (a medical technology company), including Vice President Marketing — Western Europe, Cardiac Rhythm Management from February 2002 to September 2005, Vice President Sales — US, Cardiac Surgery from September 2005 to February 2007 and Vice President Strategy and Business Development — Global, Diabetes from February 2007 to May 2008. Mr. Marver holds an M.B.A. from the Anderson School at the University of California, Los Angeles and a B.A. in Psychology from Duke University.
Matysik, Michael Michael K. Matysik has served as Senior Vice President, Chief Financial Officer and Secretary of Cardiac Science Corporation since September 2005. Mr. Matysik previously served as Senior Vice President, Chief Financial Officer and Secretary for Quinton from April 2002 to August 2005. From May 2001 to November 2001, Mr. Matysik was Executive Vice President and Chief Financial Officer of DMX Music, a global media and technology company. From September 1996 to April 2001, Mr. Matysik was Vice President and Chief Financial Officer of AEI Music Network, Inc., also a global media and technology company. He holds an M.B.A. from the University of Southern California and a B.A. in Business Administration from the University of Washington.
Odell, Robert Robert W. Odell has served as the Senior Vice President - Strategy, Design & Operations of Cardiac Science Corporation since January 2008. From October 2006 to December 2007, Mr. Odell held the position of Senior Director, Business Unit — Cardiology for Siemens Medical Solutions. From September 2005 to October 2006, he was General Manager/Vice President, Development for Analogic Corporation. From December 2002 to April 2005, Mr. Odell held the position of Vice President, Product Generation for Medtronic, Inc. From October 1998 to December 2002, he was Vice President, Global Marketing/Product Development/IT for General Electric Medical Systems. Mr. Odell holds Master of Business Administration from the University of Phoenix and a Bachelor of Science in Electrical Engineering from Syracuse University.
Kingma, Peter Mr. Peter Kingma has been appointed as Senior Vice President of Cardiac Science Corporation. Mr. Kingma worked for Siemens from 1985 to 2008 where he held a number of significant leadership roles in the cardiac technology space. He served as Global Vice President-CT Division in Germany, US Vice President and Business Manager-CT Division, and US Vice President and Business Manager-Molecular Imaging Division. He also served as Managing Director of Siemens Medical Solutions in Australia/New Zealand, and in several senior product and business management roles in Southern Africa. Mr. Kingma has lived and worked in the US, Germany, South Africa, and Australia. Mr. Kingma has an Electrical Engineering (LC) from the Cape Peninsula University of Technology in Cape Town, South Africa and executive business training from the London School of Economics and Duke University's Fuqua School of Business.
Alberstone, Todd Mr. Todd Alberstone has been appointed as Vice President, General Counsel of Cardiac Science Corporation. He has held positions as director of intellectual property management for the University of Washington, associate general counsel for Real Networks, adjunct professor at Southwestern University School of Law, as well as positions in private practice. Mr. Alberstone has an undergraduate degree in economics from the University of California, Berkeley, and received his J.D. from the University of California, Berkeley (Boalt Hall).
Titus, Ralph Ralph A. Titus has served as Vice President, Marketing of Cardiac Science Corporation since August 2007. From July 2006 to July 2007, Mr. Titus was Vice President of OEM Business Development at Masimo Corporation, a medical technology company. From June 2002 to July 2006, Mr. Titus held various positions for Medtronic Corporation, Emergency Response Systems Division, a medical device manufacturer, including Director of Business Development and Director of Global Strategic Marketing. From 1997 to 2000, Mr. Titus held various sales and sales management roles with Tyco Healthcare. Mr. Titus holds an M.B.A. in finance and operations from Cornell University and a B.A. in Marketing from Western Washington University.
Thompson, Barbara Barbara J. Thompson has served as Vice President, Human Resources of Cardiac Science Corporation since June 2007. From May 2004 through June 2007, she was Senior Director, Human Resources at Expedia, Inc., an online travel service. From February 1999 to April 2004, Ms. Thompson was the Owner/Consultant for Thompson HR, a consulting company in Kirkland, WA. From March 2001 through December 2002, she was Vice President of Human Resources for WRQ, Inc., a software company. Ms. Thompson was Vice President of Human Resources for Starwave Corporation, which became The Walt Disney Internet Group, from January 1994 to January 1999. Ms. Thompson holds an M.B.A. from the University of Washington and a B.A. in Business from the University of Northern Iowa.
Lemvigh, Kurt Kurt B. Lemvigh has served as Vice President, International of Cardiac Science Corporation since September 2005. From February 2001 to August 2005, Mr. Lemvigh served as President, International Operations for CSI. From January 2000 to February 2001, Mr. Lemvigh served as the General Manager of GE Medical Systems, Northern Europe, a medical device manufacturer. From August 1996 to December 1999, Mr. Lemvigh was the Cardiology Marketing Director for Europe, Africa and the Middle East for Marquette-Hellige, and prior to that he was the Marketing Manager for cardiology information systems and Holter monitoring products in Europe, Africa and the Middle East for Marquette-Hellige. Before joining Marquette-Hellige, Mr. Lemvigh was the Sales Director of a Danish medical distribution company for 10 years. Mr. Lemvigh holds a Merconom Business Diploma degree, with a major in Sales and Marketing, from the Niels Brock Copenhagen Business College.
Berg, W. Robert W. Robert Berg has served as one of the Directors of Cardiac Science Corporation since September 2005. From July 2002 to August 2005, Mr. Berg served as a director of Quinton. From October 1985 to January 2000, Mr. Berg held several positions at SeaMED Corporation, a medical equipment company, including Vice President of Operations from 1985 to 1987, and President and CEO from 1987 to 2000. He served as President of SeaMED until he retired in January 2000. Mr. Berg holds a B.A. from the University of Washington.
Mickelson, Timothy Timothy C. Mickelson, Ph.D. has served as one of the Directors of Cardiac Science Corporation since November 2006. From April 2003 until his retirement in May 2005, Dr. Mickelson was an Executive Vice President of Philips Medical Systems, a medical device manufacturer, and Chief Executive Officer of its Global Customer Service business. Dr. Mickelson served as the Chief Executive Officer of Philips Medical’s Ultrasound business from October 1998 until April 2003. From December 1988 until December 1997, Dr. Mickelson held various positions at Marquette Medical Systems, including Vice President of its Patient Monitoring Division, President of Corometrics Medical Systems, and President of Marquette Medical Systems from August 1995 until December 1997. Dr. Mickelson holds a Ph.D. in Physiology from Ohio University, an M.S. from Thayer School of Engineering (Dartmouth College), and a B.S. in Electrical Engineering from the University of Wisconsin.
Davis, Christopher Mr. Christopher J. Davis has been appointed to the board of directors of Cardiac Science Corporation since November 2008. Mr. Davis has been a Senior Managing Director, Chief Operating Officer, and Chief Financial Officer of Perseus LLC (a private equity fund management company) since April 2007. Prior to joining Perseus, Mr. Davis spent six years at Safeguard Scientifics, Inc. (a publicly traded holding company of growth-stage technology and life sciences businesses), where he held various positions, including Executive Vice President, Chief Administrative & Financial Officer and Vice President-Strategic Planning. Mr. Davis is a Certified Public Accountant. Mr. Davis received his Masters in Business Administration and a Bachelor of Business Administration degree from Temple University. Pursuant to a senior note and warrant conversion agreement between the Company and Perseus, LLC, entered into in connection with the 2005 merger of Cardiac Science, Inc. and Quinton Cardiology Systems, Inc., entities affiliated with Perseus, as long as such entities continue to beneficially own at least ten percent of the Company’s outstanding capital stock, have the collective right to designate one director for election to the Company’s board of directors. Mr. Davis has been nominated in accordance with this agreement.
Andrews, Ronald Mr. Ronald A. Andrews, Jr., is Director of Cardiac Science Corporation and a member of the Audit committee. He is the vice chairman and chief executive officer of Clarient, Inc. (Nasdaq: CLRT), an advanced cancer diagnostics and laboratory services company serving pathologists, oncologists, and the pharmaceutical industry. Andrews joined Clarient in July 2004 and implemented a completely new business model for the company that generated annual revenue growth from nominal levels to a run rate approaching $100 million. Prior to joining Clarient, Andrews was senior vice president global marketing and commercial business development at Pleasanton, CA-based Roche Molecular Diagnostics, where he was responsible for all aspects of strategy and commercial operations. From 2000 to 2002, Andrews held two senior executive positions with Indianapolis-based Roche Diagnostics Corporation: vice president, U.S. commercial operations, molecular diagnostics, and vice president, marketing, U.S. commercial operations. Andrews earned a bachelor's degree in biology and chemistry from Wofford College and has participated extensively in the executive development programs at Roche and Abbott Labs.

Insider Trading

Name Shares Traded Price
DAVIS CHRISTOPHER J 1,000 $0.00
MICKELSON TIMOTHY C 5,000 $3.67
COHEN RAYMOND W 1,000 $0.00
MICKELSON TIMOTHY C 1,000 $0.00
BERG W ROBERT 1,000 $0.00
NAUMANN ETIENNE RUEDIGER 1,000 $0.00
CHERN JUE HSIEN 1,000 $0.00
MARVER DAVID L 5,000 $4.05
MARVER DAVID L 5,000 $4.03
HINSON JOHN R 22,500 $0.00
HINSON JOHN R 5,952 $2.90
TAYLOR DAPHNE L 2,215 $0.00
MATYSIK MICHAEL K 2,769 $0.00
THOMPSON BARBARA L 724 $2.75
MOTAFRAM FEROZE D 2,769 $0.00
LEMVIGH KURT B 2,215 $0.00
HINSON JOHN R 1,984 $2.75
THOMPSON BARBARA L 2,215 $0.00
TAYLOR DAPHNE L 724 $2.75
MATYSIK MICHAEL K 905 $2.75
MOTAFRAM FEROZE D 1,091 $2.75
HINSON JOHN R 7,500 $0.00
NAUMANN ETIENNE RUEDIGER 3,902 $7.55
HINSON JOHN R 3,901 $7.55
NAUMANN ETIENNE RUEDIGER 3,902 $2.85
» Full list on Insider Trading
view people for: